by Chris Black
Merck is manufacturing molnupiravir at a cost of $17.74 per five-day course but charging the US government $712 for the same amount of medicine, according to a joint report by drug-pricing experts at Harvard and King’s College Hospital in London.
That’s 40 times the price for the pill that is said to cut the risk of hospitalization with Coronavirus in half, The Intercept says.
To add insult to injury, the US government spent at least $29 million on the drug’s development — $10 million from the DoD and a further $19 million from the National Institutes of Health.
Molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of Covid-19, costs $17.74 to produce, according to a new report. Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price. t.co/7SKwW257TU
— The Intercept (@theintercept) October 7, 2021
- Insanity – Dr. Fauci casually admits the vaccine was a worthless venture
- Videos and pictures from Turkey’s catastrophic earthquakes
- You May Want To Vomit After You Read About The Unspeakable Evil That Is Happening All Over America Right Now
- Zelensky & a $35 Million Estate in Florida?
- Turkey newspaper reveal the terrible dimensions of Ukraine army losses:
- Chris Sky – The True Nostradamus Of Canada And Covid Era – Now Warns You About ESG Carbon CBDC Slave System And The Future-Gym Guy
- THESE 3 Countries Are Collapsing | Civil Unrest Has Begun in Europe
- Jim Breuer: “The vaccinated were real cocky a couple of months ago…. now they’re getting sick.”
- We Are Facing a Dysgenic Disaster
- Bill Maher Takes Down Communism and Gives America a Dire Warning About ‘Woke’ Revolutionaries
Views: 7